SCHEMBL13638284

SCHEMBL13638284

C=C1CC(Nc2nccc(-c3ccc(C4CNC(=O)C4)s3)n2)CC(C)(C)N1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 5/20 0.32
CDK1 P06493 4/20 0.32
CCNB1 P14635 4/20 0.32
CCNA2 P20248 4/20 0.32
CCND1 P24385 4/20 0.32
CDK2 P24941 4/20 0.32
CCNA1 P78396 4/20 0.32
GSK3B P49841 1/20 0.32
AURKA O14965 1/20 0.31
TTK P33981 1/20 0.31
AURKB Q96GD4 1/20 0.31
INCENP Q9NQS7 1/20 0.31
MAPK8 P45983 3/20 0.31
MAPK9 P45984 2/20 0.31
MAPK10 P53779 2/20 0.31
IKBKB O14920 3/20 0.31
CCNE1 P24864 1/20 0.30
CCND3 P30281 1/20 0.30
CDK6 Q00534 1/20 0.30
MKNK1 Q9BUB5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3476963 0.88 KCNH2 (0.35) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL14612785 0.81 IKBKB (0.37) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638454 0.81 CDK4 (0.36) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638295 0.80 AKT3 (0.38) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638667 0.80 CDK1 (0.32) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638288 0.80 CDK1 (0.32) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638420 0.79 KDM4E (0.38) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638286 0.79 ROCK2 (0.35) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638461 0.79 AKT3 (0.32) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638562 0.79 IKBKB (0.39) CDK4CDK1CCNB1CCNA2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed